Kristen Stevenson
Overview
Explore the profile of Kristen Stevenson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
3910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luskin M, Shimony S, Keating J, Keating J, Winer E, Garcia J, et al.
Blood Adv
. 2024 Nov;
9(3):617-626.
PMID: 39546748
In acute lymphoblastic leukemia (ALL), the B-cell lymphoma 2 inhibitor venetoclax may enhance the efficacy of chemotherapy, allowing dose reductions. This phase 1b study of venetoclax plus attenuated chemotherapy enrolled...
2.
Zhu Q, Nambiar R, Schultz E, Gao X, Liang S, Flamand Y, et al.
Br J Haematol
. 2024 Aug;
205(5):1889-1898.
PMID: 39143423
Bone toxicities are common among paediatric patients treated for acute lymphoblastic leukaemia (ALL) with potentially major negative impact on patients' quality of life. To identify the underlying genetic contributors, we...
3.
Tsai C, Saito T, Sarangdhar M, Abu-El-Haija M, Wen L, Lee B, et al.
Sci Transl Med
. 2023 Mar;
15(687):eabn2110.
PMID: 36921036
Among drug-induced adverse events, pancreatitis is life-threatening and results in substantial morbidity. A prototype example is the pancreatitis caused by asparaginase, a crucial drug used to treat acute lymphoblastic leukemia...
4.
Kahn J, Stevenson K, Beauchemin M, Koch V, Cole P, Welch J, et al.
J Pediatr Hematol Oncol Nurs
. 2022 Oct;
40(1):17-23.
PMID: 36221984
Oral chemotherapy nonadherence is a challenge in clinical oncology. During therapy for acute lymphoblastic leukemia (ALL), poor adherence to 6-mercaptopurine (6MP) increases relapse risk. Clinically significant nonadherence is reported in...
5.
Aziz-Bose R, Zheng D, Umaretiya P, Ilcisin L, Stevenson K, Koch V, et al.
Pediatr Blood Cancer
. 2022 Sep;
69(11):e29933.
PMID: 36069432
Social determinants of health (SDoH) are associated with stark disparities in cancer outcomes, but systematic SDoH data collection is virtually absent from oncology clinical trials. Trial-based SDoH data are essential...
6.
Gotti G, Stevenson K, Kay-Green S, Blonquist T, Mantagos J, Silverman L, et al.
Pediatr Blood Cancer
. 2022 Jun;
70(1):e29833.
PMID: 35731572
No abstract available.
7.
Gotti G, Stevenson K, Kay-Green S, Blonquist T, Mantagos J, Silverman L, et al.
Pediatr Blood Cancer
. 2022 Feb;
69(4):e29542.
PMID: 35187841
Background: Ocular abnormalities (OA) in pediatric patients with acute lymphoblastic leukemia (ALL) are common findings both at diagnosis and later in follow-up. The frequency, predictors, and prognostic impact of OA...
8.
Amrein P, Ballen K, Stevenson K, Brunner A, Hobbs G, Hock H, et al.
Leuk Lymphoma
. 2022 Jan;
63(6):1428-1435.
PMID: 35075985
We sought to assess the safety of adding ixazomib, an oral proteasome inhibitor, to a multi-agent treatment regimen for older adults with acute lymphoblastic leukemia (ALL). Patients 51 to 75 ...
9.
Pollock N, Flamand Y, Zhu J, Millington K, Stevenson K, Silverman L, et al.
Pediatr Blood Cancer
. 2021 Dec;
69(7):e29505.
PMID: 34931744
Background: Chemotherapy regimens containing glucocorticoids and pegaspargase are associated with hyperglycemia; however, the pattern and underlying risk factors are not well characterized. We determined the pattern of hyperglycemia and associated...
10.
Biran A, Yin S, Kretzmer H, Ten Hacken E, Parvin S, Lucas F, et al.
Cancer Res
. 2021 Oct;
81(24):6117-6130.
PMID: 34686499
Chronic lymphocytic leukemia (CLL) is characterized by disordered DNA methylation, suggesting these epigenetic changes might play a critical role in disease onset and progression. The methyltransferase is a key regulator...